Sanofi· @sanofi · X·· 2026-06-23精选AI 评分62
AI 导读
赛诺菲宣布，欧盟委员会已批准其一款药物用于治疗特定继发性进展型多发性硬化患者。赛诺菲称此举强化了其推动科学创新以应对未满足患者需求的承诺，更多信息见其官网新闻稿。
推荐理由
欧盟委员会批准赛诺菲一款药物用于特定继发性进展型多发性硬化患者，读者可据此了解该适应症的监管进展。
正文
#NEWS: The @EU_Commission has approved our medicine for the treatment of certain people with secondary progressive #MultipleSclerosis , reinforcing our commitment to advancing scientific innovation that address unmet patient needs.
Learn more ⬇️
https://www.sanofi.com/en/media-room/press-releases/2026/2026-06-23-05-00-00-3315699
来源：Sanofi · x.com